300702SZSE

Announcement of Resolutions from the 20th Meeting of the 5th Board of Directors

✨ AI Summary

The 20th meeting of the 5th Board of Directors of Zhejiang Tianyu Pharmaceutical Co., Ltd. approved the acquisition of 87.8173% equity in Shanghai Xingke High-Purity Solvent Co., Ltd. The acquisition aligns with the company's strategic direction and is funded through internal resources and bank loans. Additionally, the board agreed to convene the first extraordinary shareholders' meeting on April 15, 2026.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

I. Meeting Information

The 20th meeting of the 5th Board of Directors of Zhejiang Tianyu Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") was held on March 30, 2026, at 9:30 AM in the first-floor conference room of the Company, combining on-site and remote voting. The meeting notice was delivered on March 25, 2026, via written, telephone, and email methods. A total of 8 directors were supposed to attend, and all 8 directors were present. The meeting was chaired by Mr. Tu Yongjun, the Chairman of the Company, with senior management in attendance. The convening of this board meeting complies with the relevant provisions of the Company Law and the Articles of Association.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.